As of April 16, 2025, Beam Therapeutics (BEAM) has a market cap of $1.73 billion USD. According to our data, Beam Therapeutics is ranked No.4206 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.73 B |
-15.99%
|
Dec 31, 2024 | $2.05 B |
-8.89%
|
Dec 29, 2023 | $2.25 B |
-30.40%
|
Dec 30, 2022 | $3.24 B |
-50.92%
|
Dec 31, 2021 | $6.60 B |
-2.39%
|
Dec 31, 2020 | $6.76 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.38 B |
-0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.44 B |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
Market Cap | = | BEAM Stock Price | * | BEAM Shares Outstanding |
= | $17.28 | * | 99.84 M | |
= | $1.73 B |